← Open Payments lookup

AMY BAREMORE: Open Payments

NPI 1578193637 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,167 in 73 payments from 13 companies in 2025. Trend: 2023 $2,144 · 2024 $1,743 · 2025 $2,167

Food & beverage: $2,167
CompanyPaymentsAmount
ABBVIE INC.28$413
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$247
Otsuka America Pharmaceutical, Inc.6$233
Vanda Pharmaceuticals Inc.11$230
Axsome Therapeutics, Inc.9$216
Supernus Pharmaceuticals, Inc.3$148
E.R. Squibb & Sons, L.L.C.2$138
Alkermes, Inc.1$129
Neurocrine BioSciences, Inc.1$124
Teva Pharmaceuticals USA, Inc.1$123

Products named: VRAYLAR, REXULTI, CAPLYTA, Auvelity, FANAPT, Qelbree, COBENFY, LYBALVI.

Industry payments across MO — which companies pay providers there.